Recommended items to address in a clinical trial protocol and related documents. (DOCX 49 kb
Information of 277 eligible Trials with ClinicalTrials.gov identification numbers in this study. (XL...
Table S2. Focal amplification in case 3. Summary of the gene amplification in case 3. (XLSX 10 kb
Local ethics committees. List of all ethics committees which approved the study protocol. (PDF 14 kb
Contains fulltext : 202604.pdf (publisher's version ) (Open Access
SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...
Background: Approximately 20-30% of patients with pT4 colon cancer develop metachronous peritoneal m...
Inclusion and exclusion criteria of the PERISCOPE II trial. List of all in and exclusion criteria. (...
Summary of chemotherapies for metastatic colorectal cancer in the various setting. (PDF 133Â kb
Schematic diagram depicting complete mobilization of mesocolon. The plane of dissection lies between...
Trial visits in Arm B. Example of visits and documented parameters for chemotherapy regimen with eig...
Collaborating centres in the IPPCollapse-II study and expected number of patients recruited. (DOCX 1...
Table S1. Coverage details. Summary of the sequencing coverage depth in each sample. (XLSX 10 kb
SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documen...
Table listing the Central ethics committee and the IRBs of the participating institutes. The IRB of ...
Timeline of the case. Time line: The âtimelineâ visualizes the course of treatment of the patien...
Information of 277 eligible Trials with ClinicalTrials.gov identification numbers in this study. (XL...
Table S2. Focal amplification in case 3. Summary of the gene amplification in case 3. (XLSX 10 kb
Local ethics committees. List of all ethics committees which approved the study protocol. (PDF 14 kb
Contains fulltext : 202604.pdf (publisher's version ) (Open Access
SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...
Background: Approximately 20-30% of patients with pT4 colon cancer develop metachronous peritoneal m...
Inclusion and exclusion criteria of the PERISCOPE II trial. List of all in and exclusion criteria. (...
Summary of chemotherapies for metastatic colorectal cancer in the various setting. (PDF 133Â kb
Schematic diagram depicting complete mobilization of mesocolon. The plane of dissection lies between...
Trial visits in Arm B. Example of visits and documented parameters for chemotherapy regimen with eig...
Collaborating centres in the IPPCollapse-II study and expected number of patients recruited. (DOCX 1...
Table S1. Coverage details. Summary of the sequencing coverage depth in each sample. (XLSX 10 kb
SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documen...
Table listing the Central ethics committee and the IRBs of the participating institutes. The IRB of ...
Timeline of the case. Time line: The âtimelineâ visualizes the course of treatment of the patien...
Information of 277 eligible Trials with ClinicalTrials.gov identification numbers in this study. (XL...
Table S2. Focal amplification in case 3. Summary of the gene amplification in case 3. (XLSX 10 kb
Local ethics committees. List of all ethics committees which approved the study protocol. (PDF 14 kb